It’s mission critical this time as biotech looks to bounce back

9-11 January 2023, San Francisco

We’ve gone quite a stretch without a live JP Morgan conference. Now it’s time to fix that. Getting together, exploring new deals, hoping someone uncorks a whopper of a buyout, all while assessing the year ahead — these are all annual traditions set to make a comeback at the start of 2023. And this year Endpoints News will be at the heart of it all, offering a hybrid slate of events that will be both live and streaming.

That Monday through Wednesday we’ll have a jam packed calendar of panel conversations and firesides with prominent industry execs that you can tune into online. Our in-person event in San Francisco will offer live AM sessions and a coworking space starting in the afternoon on both Monday and Tuesday. We’ll cap off the event with virtual sessions on Wednesday.

9-11
jan 2023 San Francisco
3
days of live and virtual programming + livestream
12
panels and fireside chats with industry leaders
12h
of co-working space brought to you by Endpoints Insider

sponsored by

7:35 - 8:00am PST 22:00-22:30 local time

Fireside chat

7:35 - 8:00am PST 22:00-22:30 local time

An in-depth discussion featuring Sage CEO Barry Greene and Endpoints’ EIC John Carroll.

sponsored by Catalent
Barry Greene
Barry Greene
CEO
Sage Therapeutics
John Carroll
John Carroll
Founder & Editor
Endpoints News
8:30 - 9:00am PST 22:00-22:30 local time

The biopharma industry in 2023

8:30 - 9:00am PST 22:00-22:30 local time

Endpoints EIC John Carroll joins Catalent’s Alessandro Maselli to chart the waters ahead for biopharma.

sponsored by Catalent
Alessandro Maselli
Alessandro Maselli
President & CEO
Catalent
John Carroll
John Carroll
Founder & Editor
Endpoints News
9:15 - 10:15am PST (22:00-22:30 local time)

Dealmaking in 2023

9:15 - 10:15am PST (22:00-22:30 local time)

Our panel of veteran industry dealmakers will take a look at the top trends as we enter a new year at the bargaining table.

sponsored by
Glenn Hunzinger
Glenn Hunzinger
Pharmaceutical and Life Sciences Consulting Solutions Leader
PwC US
Sunil Patel
Sunil Patel
SVP and Head of Business Development & Licensing
Merck
Debbie Baron
Debbie Baron
SVB, Worldwide BD
Pfizer
James H. Sabry
James H. Sabry
Global Head of Pharma Partnering
Roche
John Carroll
John Carroll
Founder & Editor
Endpoints News
moderator
10:30 - 11:30am PST 22:00-22:30 local time

What's really driving the cost of healthcare and drugs in 2023?

10:30 - 11:30am PST 22:00-22:30 local time

Stay tuned, details coming soon.

sponsored by
Stephen J. Ubl
Stephen J. Ubl
President and Chief Executive Officer
PhRMA
Drew Armstrong
Drew Armstrong
Executive Editor
Endpoints News
moderator
8:00 - 8:25am PST 22:00-22:30 local time

Fireside chat

8:00 - 8:25am PST 22:00-22:30 local time

An in-depth discussion featuring Endpoints EIC John Carroll and ARCH’s Robert Nelson.

Robert Nelsen
Robert Nelsen
Co-founder & Managing Director
ARCH Venture Partners
John Carroll
John Carroll
Founder & Editor
Endpoints News
8:40 - 9:35am PST 22:00-22:30 local time

Panel to be announced

8:40 - 9:35am PST 22:00-22:30 local time

An in-depth discussion on communication, information and transparency in biopharma.

sponsored By
Rachi Govil
Rachi Govil
Executive Vice President, Healthcare Practice Lead, North America
BCW
Arsalan Arif
Arsalan Arif
Founder & Publisher
Endpoints News
moderator
9:50 - 10:45am PST 22:00-22:30 local time

AI in biopharma 2023 — there's no looking back

9:50 - 10:45am PST 22:00-22:30 local time

From discovery through trials, we're beyond the early stages of AI in biotech R&D. When the mission is to get to patients faster, drug developers are increasingly looking at technology for the answers. Beyond the initial hype, where is AI poised to make meaningful contributions to R&D? Endpoints publisher Arsalan Arif is convening a panel of leading experts to discuss the state of AI in biotech and the outlook for 2023. How are we getting higher quality targets into clinical trials? How is AI playing a role in clinical trial design? What's the impact of protein structure predicting in drug discovery? What's the outlook for AI in 2023?

sponsored by
Charles Fisher
Charles Fisher
Founder and CEO
Unlearn
11:00am - 12:00pm PST 22:00-22:30 local time

This is how we cure cancer

11:00am - 12:00pm PST 22:00-22:30 local time

One of the key trends in oncology R&D right now is moving new cancer therapies into the adjuvant arena, combining with better diagnostics and earlier diagnosis to hit cancer at a point it can still be forced into remission. In this roundtable discussion we’ll look at some of the latest advances in combinations and early detection that will give patients the best shot at a curative therapeutic program. Moderated by John Carroll.

sponsored By Foundation Medicine
George Addona
George Addona
Senior Vice President, Head, Discovery Preclinical and Translational Medicine
Merck
Kristen Hege
Kristen Hege
SVP, Early Clinical Development, Oncology/Hematology and Cell Therapy
BMS
Shiva Malek
Shiva Malek
Global Head of Oncology 
NIBR
Brian Alexander
Brian Alexander
Chief Executive Officer
Foundation Medicine
Aviv Regev
Aviv Regev
Head
Genentech Research and Early Development
John Carroll
John Carroll
Founder & Editor
Endpoints News
moderator
8:30 - 9:30am PST 22:00-22:30 local time

The Year Ahead in Washington

8:30 - 9:30am PST 22:00-22:30 local time

A split Congress means little if any legislation is likely to advance this year. What are the must-do pieces of legislation that might be vehicles for action? What should the biopharma industry expect from a Republican House's oversight efforts? And with the 2024 presidential campaigns already gearing up, how will the noise from electoral politics affect markets corporate planning?

9:45 - 10:15am PST 22:00-22:30 local time

Fireside Chat

9:45 - 10:15am PST 22:00-22:30 local time

One-on-one chat featuring a member of the Endpoints editorial team and an industry leader.

10:30 - 11:30am PST 22:00-22:30 local time

Capital Markets

10:30 - 11:30am PST 22:00-22:30 local time

A look at the environment for fundraising. How are venture capitalists and other private investors thinking about deploying and raising capital? What's the appetite for exits? In a down market with financial pressure on company balance sheets, what types of financings should we expect to see?

Co-working lounge

monday & tuesday - 12:00pm - 6:00pm PST

Network with Endpoints Insiders in our premium space just blocks away from Union Square. Perks include unlimited coffee, WiFi, charging station, lounge-style seating with coworking tables and a chance to mingle with members of the Endpoints team. Endpoints Insider subscription or full-day pass is required to attend.

Register for virtual & livestream

Livestream
VIRTUAL

No cost to register, subject to confirmation. By registering for this event, you accept that you may receive direct communication from the sponsor(s).

If you are experiencing problems with your registration, please contact our support team.